Ontology highlight
ABSTRACT:
SUBMITTER: Irvin WJ
PROVIDER: S-EPMC3158597 | biostudies-literature | 2011 Aug
REPOSITORIES: biostudies-literature
Irvin William J WJ Walko Christine M CM Weck Karen E KE Ibrahim Joseph G JG Chiu Wing K WK Dees E Claire EC Moore Susan G SG Olajide Oludamilola A OA Graham Mark L ML Canale Sean T ST Raab Rachel E RE Corso Steven W SW Peppercorn Jeffrey M JM Anderson Steven M SM Friedman Kenneth J KJ Ogburn Evan T ET Desta Zeruesenay Z Flockhart David A DA McLeod Howard L HL Evans James P JP Carey Lisa A LA
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110718 24
<h4>Purpose</h4>We examined the feasibility of using CYP2D6 genotyping to determine optimal tamoxifen dose and investigated whether the key active tamoxifen metabolite, endoxifen, could be increased by genotype-guided tamoxifen dosing in patients with intermediate CYP2D6 metabolism.<h4>Patients and methods</h4>One hundred nineteen patients on tamoxifen 20 mg daily ≥ 4 months and not on any strong CYP2D6 inhibiting medications were assayed for CYP2D6 genotype and plasma tamoxifen metabolite conce ...[more]